Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy.

[1]  B. Luxembourg,et al.  Evidence-based indications for thrombophilia screening. , 2008, VASA. Zeitschrift fur Gefasskrankheiten.

[2]  K. Curtis,et al.  Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review. , 2006, Contraception.

[3]  A. Nicolaides,et al.  Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. , 2005, International angiology : a journal of the International Union of Angiology.

[4]  A. Nicolaides.  Chronic Venous Disease, Inflammation, and Daflon 500 mg , 2005, Angiology.

[5]  F. Rosendaal,et al.  Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate , 2004, Journal of thrombosis and haemostasis : JTH.

[6]  J. Rosing,et al.  Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. , 2003, The Journal of clinical endocrinology and metabolism.

[7]  A. Dobs,et al.  Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. , 2003, The Journal of clinical endocrinology and metabolism.

[8]  P. Wells,et al.  Risk of venous thromboembolism in relatives of symptomatic probands with thrombophilia: a systematic review , 2003, Thrombosis and Haemostasis.

[9]  P. Ockelford,et al.  Screening for a prothrombotic diathesis in patients attending family planning clinics. , 1999, The New Zealand medical journal.

[10]  Paul van Kesteren,et al.  An epidemiological and demographic study of transsexuals in the Netherlands , 1996, Archives of sexual behavior.

[11]  J. Clegg,et al.  World distribution of factor V Leiden , 1995, The Lancet.

[12]  M. Trossaërt,et al.  Modified APC resistance assay for patients on oral anticoagulants , 1994, The Lancet.

[13]  J. Aznar,et al.  Modified test for activated protein C resistance , 1994, The Lancet.

[14]  A. Walker,et al.  Mortality among oral contraceptive users , 1987, BMJ.

[15]  D. Aharony,et al.  Testosterone Potentiation of Ionophore and ADP Induced Platelet Aggregation : Relationship to Arachidonic Acid Metabolism , 1981, Thrombosis and Haemostasis.

[16]  S. Murota,et al.  Testosterone inhibits prostacyclin production by rat aortic smooth muscle cells in culture. , 1981, Atherosclerosis.

[17]  V. Beral.  MORTALITY AMONG ORAL-CONTRACEPTIVE USERS Royal College of General Practitioners' Oral Contraception Study , 1977, The Lancet.

[18]  E. Giltay,et al.  Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. , 2008, The Journal of clinical endocrinology and metabolism.

[19]  Arnold Simanowitz,et al.  international consensus statement , 2000 .